APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pediatric Vaccines Industry Growth and Trends Forecast to 2032

27 December 2025124 pages

Choose your research edition.

Industry ResearchPediatric Vaccines Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Pediatric Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pediatric Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pediatric Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pediatric Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pediatric Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pediatric Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pediatric Vaccines Market by Company

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

S K Chemicals

Serum Institute of India

Sinovac Biotech

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Takeda Pharmaceutical

Janssen

Pediatric Vaccines Segment by Type

Meningococcal Diseases

Influenza

Hepatitis

Pneumococcal Diseases

Diphtheria

Others

Pediatric Vaccines Segment by Application

Infant

Newborn

Dolescent

Child

Pediatric Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Meningococcal Diseases Table 2. Major Company of Influenza Table 3. Major Company of Hepatitis Table 4. Major Company of Pneumococcal Diseases Table 5. Major Company of Diphtheria Table 6. Major Company of Others Table 7. Global Pediatric Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 9. Global Pediatric Vaccines Sales Market Share in Volume by Type (2021-2026) Table 10. Global Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 11. Global Pediatric Vaccines Sales Market Share in Value by Type (2021-2026) Table 12. Global Pediatric Vaccines Price by Type (2021-2026) & (US$/Unit) Table 13. Global Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 14. Global Pediatric Vaccines Sales Market Share in Volume by Type (2027-2032) Table 15. Global Pediatric Vaccines Sales by Type (2027-2032) & (US$ Million) Table 16. Global Pediatric Vaccines Sales Market Share in Value by Type (2027-2032) Table 17. Global Pediatric Vaccines Price by Type (2027-2032) & (US$/Unit) Table 18. North America Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 19. North America Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 21. Europe Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 25. Latin America Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Pediatric Vaccines Sales by Type (2021-2026) & (US$ Million) Table 28. Pediatric Vaccines Industry Trends Table 29. Pediatric Vaccines Industry Drivers Table 30. Pediatric Vaccines Industry Opportunities and Challenges Table 31. Pediatric Vaccines Industry Restraints Table 32. Global Pediatric Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Pediatric Vaccines Revenue Market Share by Company (2021-2026) Table 34. Global Pediatric Vaccines Sales by Company (2021-2026) & (W Units) Table 35. Global Pediatric Vaccines Sales Share by Company (2021-2026) Table 36. Global Pediatric Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Pediatric Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Pediatric Vaccines Major Company Production Sites and Headquarters Table 39. Global Pediatric Vaccines Company, Product Type & Application Table 40. Global Pediatric Vaccines Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Pediatric Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Pediatric Vaccines Sales by Region (2021-2026) & (W Units) Table 45. Global Pediatric Vaccines Sales Market Share in Volume by Region (2021-2026) Table 46. Global Pediatric Vaccines Sales by Region (2021-2026) & (US$ Million) Table 47. Global Pediatric Vaccines Sales Market Share in Value by Region (2021-2026) Table 48. Global Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Pediatric Vaccines Sales by Region (2027-2032) & (W Units) Table 50. Global Pediatric Vaccines Sales Market Share in Volume by Region (2027-2032) Table 51. Global Pediatric Vaccines Sales by Region (2027-2032) & (US$ Million) Table 52. Global Pediatric Vaccines Sales Market Share in Value by Region (2027-2032) Table 53. Global Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Pediatric Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 56. Global Pediatric Vaccines Sales Market Share in Volume by Application (2021-2026) Table 57. Global Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 58. Global Pediatric Vaccines Sales Market Share in Value by Application (2021-2026) Table 59. Global Pediatric Vaccines Price by Application (2021-2026) & (US$/Unit) Table 60. Global Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 61. Global Pediatric Vaccines Sales Market Share in Volume by Application (2027-2032) Table 62. Global Pediatric Vaccines Sales by Application (2027-2032) & (US$ Million) Table 63. Global Pediatric Vaccines Sales Market Share in Value by Application (2027-2032) Table 64. Global Pediatric Vaccines Price by Application (2027-2032) & (US$/Unit) Table 65. North America Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 66. North America Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 68. Europe Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 72. Latin America Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Pediatric Vaccines Sales by Application (2021-2026) & (US$ Million) Table 75. Bavarian Nordic Company Information Table 76. Bavarian Nordic Business Overview Table 77. Bavarian Nordic Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bavarian Nordic Pediatric Vaccines Product Portfolio Table 79. Bavarian Nordic Recent Development Table 80. Bharat Biotech Company Information Table 81. Bharat Biotech Business Overview Table 82. Bharat Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Bharat Biotech Pediatric Vaccines Product Portfolio Table 84. Bharat Biotech Recent Development Table 85. Crucell Company Information Table 86. Crucell Business Overview Table 87. Crucell Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Crucell Pediatric Vaccines Product Portfolio Table 89. Crucell Recent Development Table 90. Dynavax Company Information Table 91. Dynavax Business Overview Table 92. Dynavax Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Dynavax Pediatric Vaccines Product Portfolio Table 94. Dynavax Recent Development Table 95. LG Life Sciences Company Information Table 96. LG Life Sciences Business Overview Table 97. LG Life Sciences Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. LG Life Sciences Pediatric Vaccines Product Portfolio Table 99. LG Life Sciences Recent Development Table 100. Lupin Company Information Table 101. Lupin Business Overview Table 102. Lupin Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Lupin Pediatric Vaccines Product Portfolio Table 104. Lupin Recent Development Table 105. Mitsubishi Tanabe Pharma Company Information Table 106. Mitsubishi Tanabe Pharma Business Overview Table 107. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio Table 109. Mitsubishi Tanabe Pharma Recent Development Table 110. S K Chemicals Company Information Table 111. S K Chemicals Business Overview Table 112. S K Chemicals Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. S K Chemicals Pediatric Vaccines Product Portfolio Table 114. S K Chemicals Recent Development Table 115. Serum Institute of India Company Information Table 116. Serum Institute of India Business Overview Table 117. Serum Institute of India Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Serum Institute of India Pediatric Vaccines Product Portfolio Table 119. Serum Institute of India Recent Development Table 120. Sinovac Biotech Company Information Table 121. Sinovac Biotech Business Overview Table 122. Sinovac Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Sinovac Biotech Pediatric Vaccines Product Portfolio Table 124. Sinovac Biotech Recent Development Table 125. AstraZeneca Company Information Table 126. AstraZeneca Business Overview Table 127. AstraZeneca Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. AstraZeneca Pediatric Vaccines Product Portfolio Table 129. AstraZeneca Recent Development Table 130. Baxter Company Information Table 131. Baxter Business Overview Table 132. Baxter Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Baxter Pediatric Vaccines Product Portfolio Table 134. Baxter Recent Development Table 135. GlaxoSmithKline Company Information Table 136. GlaxoSmithKline Business Overview Table 137. GlaxoSmithKline Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. GlaxoSmithKline Pediatric Vaccines Product Portfolio Table 139. GlaxoSmithKline Recent Development Table 140. Pfizer Company Information Table 141. Pfizer Business Overview Table 142. Pfizer Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Pfizer Pediatric Vaccines Product Portfolio Table 144. Pfizer Recent Development Table 145. Merck Company Information Table 146. Merck Business Overview Table 147. Merck Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Merck Pediatric Vaccines Product Portfolio Table 149. Merck Recent Development Table 150. Novartis Company Information Table 151. Novartis Business Overview Table 152. Novartis Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Novartis Pediatric Vaccines Product Portfolio Table 154. Novartis Recent Development Table 155. Sanofi Company Information Table 156. Sanofi Business Overview Table 157. Sanofi Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Sanofi Pediatric Vaccines Product Portfolio Table 159. Sanofi Recent Development Table 160. Shenzhen Kangtai Biological Products Company Information Table 161. Shenzhen Kangtai Biological Products Business Overview Table 162. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio Table 164. Shenzhen Kangtai Biological Products Recent Development Table 165. Takeda Pharmaceutical Company Information Table 166. Takeda Pharmaceutical Business Overview Table 167. Takeda Pharmaceutical Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Takeda Pharmaceutical Pediatric Vaccines Product Portfolio Table 169. Takeda Pharmaceutical Recent Development Table 170. Janssen Company Information Table 171. Janssen Business Overview Table 172. Janssen Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Janssen Pediatric Vaccines Product Portfolio Table 174. Janssen Recent Development Table 175. North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 176. North America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 177. North America Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 178. North America Pediatric Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 179. North America Pediatric Vaccines Sales Market Share Forecast by Country (2027-2032) Table 180. North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. North America Pediatric Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 182. North America Pediatric Vaccines Market Share by Country (2021-2026) Table 183. North America Pediatric Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. North America Pediatric Vaccines Market Share Forecast by Country (2027-2032) Table 185. Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 186. Europe Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 187. Europe Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 188. Europe Pediatric Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 189. Europe Pediatric Vaccines Sales Market Share Forecast by Country (2027-2032) Table 190. Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Europe Pediatric Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 192. Europe Pediatric Vaccines Market Share by Country (2021-2026) Table 193. Europe Pediatric Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Europe Pediatric Vaccines Market Share Forecast by Country (2027-2032) Table 195. Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 196. Asia-Pacific Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 197. Asia-Pacific Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 198. Asia-Pacific Pediatric Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 199. Asia-Pacific Pediatric Vaccines Sales Market Share Forecast by Country (2027-2032) Table 200. Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Asia-Pacific Pediatric Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 202. Asia-Pacific Pediatric Vaccines Market Share by Country (2021-2026) Table 203. Asia-Pacific Pediatric Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Asia-Pacific Pediatric Vaccines Market Share Forecast by Country (2027-2032) Table 205. Latin America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 206. Latin America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 207. Latin America Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 208. Latin America Pediatric Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 209. Latin America Pediatric Vaccines Sales Market Share Forecast by Country (2027-2032) Table 210. Latin America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Latin America Pediatric Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 212. Latin America Pediatric Vaccines Market Share by Country (2021-2026) Table 213. Latin America Pediatric Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Latin America Pediatric Vaccines Market Share Forecast by Country (2027-2032) Table 215. Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 216. Middle East and Africa Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 217. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 218. Middle East and Africa Pediatric Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 219. Middle East and Africa Pediatric Vaccines Sales Market Share Forecast by Country (2027-2032) Table 220. Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 221. Middle East and Africa Pediatric Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 222. Middle East and Africa Pediatric Vaccines Market Share by Country (2021-2026) Table 223. Middle East and Africa Pediatric Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 224. Middle East and Africa Pediatric Vaccines Market Share Forecast by Country (2027-2032) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Pediatric Vaccines Distributors List Table 228. Pediatric Vaccines Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Pediatric Vaccines Image Figure 2. Global Pediatric Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Vaccines Sales (2021-2032) & (W Units) Figure 5. Meningococcal Diseases Image Figure 6. Global Meningococcal Diseases Sales YoY Growth (2021-2032) & (W Units) Figure 7. Influenza Image Figure 8. Global Influenza Sales YoY Growth (2021-2032) & (W Units) Figure 9. Hepatitis Image Figure 10. Global Hepatitis Sales YoY Growth (2021-2032) & (W Units) Figure 11. Pneumococcal Diseases Image Figure 12. Global Pneumococcal Diseases Sales YoY Growth (2021-2032) & (W Units) Figure 13. Diphtheria Image Figure 14. Global Diphtheria Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Pediatric Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Pediatric Vaccines Market Share by Type 2025 VS 2032 Figure 19. North America Pediatric Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. North America Pediatric Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Europe Pediatric Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Europe Pediatric Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Latin America Pediatric Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Pediatric Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Infant Image Figure 32. Global Infant Sales YoY Growth (2021-2032) & (W Units) Figure 33. Newborn Image Figure 34. Global Newborn Sales YoY Growth (2021-2032) & (W Units) Figure 35. Dolescent Image Figure 36. Global Dolescent Sales YoY Growth (2021-2032) & (W Units) Figure 37. Child Image Figure 38. Global Child Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Pediatric Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Pediatric Vaccines Market Share by Application 2025 VS 2032 Figure 41. North America Pediatric Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. North America Pediatric Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Europe Pediatric Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Europe Pediatric Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Latin America Pediatric Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Pediatric Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Application in 2025 Figure 51. North America Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Pediatric Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Pediatric Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Pediatric Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Pediatric Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Pediatric Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Pediatric Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Pediatric Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Pediatric Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Pediatric Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Pediatric Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Pediatric Vaccines Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Pediatric Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Diseases
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Diphtheria
  • Others
Applications
  • Infant
  • Newborn
  • Dolescent
  • Child
Companies covered
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Takeda Pharmaceutical
  • Janssen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pediatric Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pediatric Vaccines Market by Type
  6. 1.3.1 Meningococcal Diseases
  7. 1.3.2 Influenza
  8. 1.3.3 Hepatitis
  9. 1.3.4 Pneumococcal Diseases
  10. 1.3.5 Diphtheria
  11. 1.3.6 Others
  12. 1.4 Global Pediatric Vaccines Market Size by Type
  13. 1.4.1 Global Pediatric Vaccines Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Pediatric Vaccines Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Pediatric Vaccines Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Pediatric Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Pediatric Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Pediatric Vaccines Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pediatric Vaccines Industry Trends
  2. 2.2 Pediatric Vaccines Industry Drivers
  3. 2.3 Pediatric Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pediatric Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Pediatric Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Pediatric Vaccines Price (2021-2026)
  4. 3.4 Global Pediatric Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Pediatric Vaccines Company, Product Type & Application
  7. 3.7 Global Pediatric Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Vaccines Tier 1, Tier 2, and Tier 3
4 Pediatric Vaccines Regional Status and Outlook
  1. 4.1 Global Pediatric Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pediatric Vaccines Historic Market Size by Region
  3. 4.2.1 Global Pediatric Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pediatric Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pediatric Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pediatric Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Pediatric Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pediatric Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pediatric Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pediatric Vaccines by Application
  1. 5.1 Pediatric Vaccines Market by Application
  2. 5.1.1 Infant
  3. 5.1.2 Newborn
  4. 5.1.3 Dolescent
  5. 5.1.4 Child
  6. 5.2 Global Pediatric Vaccines Market Size by Application
  7. 5.2.1 Global Pediatric Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pediatric Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pediatric Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pediatric Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pediatric Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pediatric Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bavarian Nordic
  2. 6.1.1 Bavarian Nordic Company Information
  3. 6.1.2 Bavarian Nordic Business Overview
  4. 6.1.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
  6. 6.1.5 Bavarian Nordic Recent Developments
  7. 6.2 Bharat Biotech
  8. 6.2.1 Bharat Biotech Company Information
  9. 6.2.2 Bharat Biotech Business Overview
  10. 6.2.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
  12. 6.2.5 Bharat Biotech Recent Developments
  13. 6.3 Crucell
  14. 6.3.1 Crucell Company Information
  15. 6.3.2 Crucell Business Overview
  16. 6.3.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Crucell Pediatric Vaccines Product Portfolio
  18. 6.3.5 Crucell Recent Developments
  19. 6.4 Dynavax
  20. 6.4.1 Dynavax Company Information
  21. 6.4.2 Dynavax Business Overview
  22. 6.4.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dynavax Pediatric Vaccines Product Portfolio
  24. 6.4.5 Dynavax Recent Developments
  25. 6.5 LG Life Sciences
  26. 6.5.1 LG Life Sciences Company Information
  27. 6.5.2 LG Life Sciences Business Overview
  28. 6.5.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
  30. 6.5.5 LG Life Sciences Recent Developments
  31. 6.6 Lupin
  32. 6.6.1 Lupin Company Information
  33. 6.6.2 Lupin Business Overview
  34. 6.6.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin Pediatric Vaccines Product Portfolio
  36. 6.6.5 Lupin Recent Developments
  37. 6.7 Mitsubishi Tanabe Pharma
  38. 6.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 6.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 6.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
  42. 6.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 6.8 S K Chemicals
  44. 6.8.1 S K Chemicals Company Information
  45. 6.8.2 S K Chemicals Business Overview
  46. 6.8.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
  48. 6.8.5 S K Chemicals Recent Developments
  49. 6.9 Serum Institute of India
  50. 6.9.1 Serum Institute of India Company Information
  51. 6.9.2 Serum Institute of India Business Overview
  52. 6.9.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
  54. 6.9.5 Serum Institute of India Recent Developments
  55. 6.10 Sinovac Biotech
  56. 6.10.1 Sinovac Biotech Company Information
  57. 6.10.2 Sinovac Biotech Business Overview
  58. 6.10.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
  60. 6.10.5 Sinovac Biotech Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Baxter
  68. 6.12.1 Baxter Company Information
  69. 6.12.2 Baxter Business Overview
  70. 6.12.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Baxter Pediatric Vaccines Product Portfolio
  72. 6.12.5 Baxter Recent Developments
  73. 6.13 GlaxoSmithKline
  74. 6.13.1 GlaxoSmithKline Company Information
  75. 6.13.2 GlaxoSmithKline Business Overview
  76. 6.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
  78. 6.13.5 GlaxoSmithKline Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Pfizer Pediatric Vaccines Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Merck
  86. 6.15.1 Merck Company Information
  87. 6.15.2 Merck Business Overview
  88. 6.15.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Merck Pediatric Vaccines Product Portfolio
  90. 6.15.5 Merck Recent Developments
  91. 6.16 Novartis
  92. 6.16.1 Novartis Company Information
  93. 6.16.2 Novartis Business Overview
  94. 6.16.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Novartis Pediatric Vaccines Product Portfolio
  96. 6.16.5 Novartis Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Pediatric Vaccines Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Shenzhen Kangtai Biological Products
  104. 6.18.1 Shenzhen Kangtai Biological Products Company Information
  105. 6.18.2 Shenzhen Kangtai Biological Products Business Overview
  106. 6.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
  108. 6.18.5 Shenzhen Kangtai Biological Products Recent Developments
  109. 6.19 Takeda Pharmaceutical
  110. 6.19.1 Takeda Pharmaceutical Company Information
  111. 6.19.2 Takeda Pharmaceutical Business Overview
  112. 6.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
  114. 6.19.5 Takeda Pharmaceutical Recent Developments
  115. 6.20 Janssen
  116. 6.20.1 Janssen Company Information
  117. 6.20.2 Janssen Business Overview
  118. 6.20.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Janssen Pediatric Vaccines Product Portfolio
  120. 6.20.5 Janssen Recent Developments
7 North America by Country
  1. 7.1 North America Pediatric Vaccines Sales by Country
  2. 7.1.1 North America Pediatric Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pediatric Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Pediatric Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pediatric Vaccines Market Size by Country
  6. 7.2.1 North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pediatric Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Pediatric Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pediatric Vaccines Sales by Country
  2. 8.1.1 Europe Pediatric Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pediatric Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Pediatric Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pediatric Vaccines Market Size by Country
  6. 8.2.1 Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pediatric Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pediatric Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pediatric Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Pediatric Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pediatric Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pediatric Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pediatric Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pediatric Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pediatric Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pediatric Vaccines Sales by Country
  2. 10.1.1 South America Pediatric Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pediatric Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Pediatric Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pediatric Vaccines Market Size by Country
  6. 10.2.1 South America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pediatric Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Pediatric Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pediatric Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Pediatric Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pediatric Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pediatric Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pediatric Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pediatric Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pediatric Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pediatric Vaccines Value Chain Analysis
  2. 12.1.1 Pediatric Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pediatric Vaccines Production Mode & Process
  7. 12.2 Pediatric Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pediatric Vaccines Distributors
  10. 12.2.3 Pediatric Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst